Dominik Feuerbach

3.1k total citations
75 papers, 2.4k citations indexed

About

Dominik Feuerbach is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Dominik Feuerbach has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 9 papers in Pharmacology. Recurrent topics in Dominik Feuerbach's work include Receptor Mechanisms and Signaling (45 papers), Nicotinic Acetylcholine Receptors Study (45 papers) and Ion channel regulation and function (23 papers). Dominik Feuerbach is often cited by papers focused on Receptor Mechanisms and Signaling (45 papers), Nicotinic Acetylcholine Receptors Study (45 papers) and Ion channel regulation and function (23 papers). Dominik Feuerbach collaborates with scholars based in Switzerland, United States and Argentina. Dominik Feuerbach's co-authors include Hans O. Kalkman, Hugo R. Arias, Daniël Hoyer, Krzysztof Jóźwiak, Katarzyna M. Targowska‐Duda, Philippe Schoeffter, Joachim Nozulak, Sandra Siehler, Caroline Nunn and Hans-Gerhard Burgert and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The EMBO Journal.

In The Last Decade

Dominik Feuerbach

75 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominik Feuerbach Switzerland 31 1.4k 593 394 338 282 75 2.4k
Izumi Hide Japan 26 1.0k 0.7× 704 1.2× 568 1.4× 228 0.7× 641 2.3× 70 2.8k
Eric Ronken Netherlands 23 919 0.6× 824 1.4× 392 1.0× 195 0.6× 227 0.8× 44 2.1k
Marco Feligioni Italy 31 1.1k 0.8× 663 1.1× 391 1.0× 193 0.6× 530 1.9× 65 2.3k
Gabriel Olmos Spain 30 1.3k 0.9× 1.3k 2.2× 448 1.1× 147 0.4× 406 1.4× 61 2.8k
Kerstin Iverfeldt Sweden 30 1.2k 0.8× 993 1.7× 711 1.8× 186 0.6× 927 3.3× 57 2.9k
Agnès Petit-Paitel France 20 797 0.6× 462 0.8× 298 0.8× 306 0.9× 853 3.0× 38 2.0k
Marta Barrachina Spain 30 1.3k 0.9× 651 1.1× 484 1.2× 143 0.4× 706 2.5× 45 2.8k
Umesh K. Jinwal United States 32 2.1k 1.4× 350 0.6× 228 0.6× 279 0.8× 974 3.5× 57 3.1k
Ada De Luigi Italy 27 1.2k 0.8× 939 1.6× 1.1k 2.8× 199 0.6× 631 2.2× 54 3.2k
Anna R. Carta Italy 32 983 0.7× 1.5k 2.6× 850 2.2× 271 0.8× 582 2.1× 75 3.5k

Countries citing papers authored by Dominik Feuerbach

Since Specialization
Citations

This map shows the geographic impact of Dominik Feuerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Feuerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Feuerbach more than expected).

Fields of papers citing papers by Dominik Feuerbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Feuerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Feuerbach. The network helps show where Dominik Feuerbach may publish in the future.

Co-authorship network of co-authors of Dominik Feuerbach

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Feuerbach. A scholar is included among the top collaborators of Dominik Feuerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Feuerbach. Dominik Feuerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neri, Marilisa, Mario Bernhard, Irena Brzak, et al.. (2022). Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer’s disease. Cell Reports. 39(9). 110883–110883. 33 indexed citations
2.
Arias, Hugo R., et al.. (2018). Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms. The International Journal of Biochemistry & Cell Biology. 100. 1–10. 10 indexed citations
3.
Barch, Deanna M., Stephen R. Marder, Michael P. Harms, et al.. (2016). Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 71. 66–75. 9 indexed citations
4.
Andersen, Natalia, et al.. (2016). Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective. Neuropharmacology. 107. 189–200. 55 indexed citations
5.
Kalkman, Hans O. & Dominik Feuerbach. (2016). Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders. Cellular and Molecular Life Sciences. 73(13). 2511–2530. 139 indexed citations
6.
Arias, Hugo R., Dominik Feuerbach, & Marcelo O. Ortells. (2015). Functional and structural interaction of (−)-lobeline with human α4β2 and α4β4 nicotinic acetylcholine receptor subtypes. The International Journal of Biochemistry & Cell Biology. 64. 15–24. 6 indexed citations
7.
Arias, Hugo R., Dominik Feuerbach, Katarzyna M. Targowska‐Duda, et al.. (2014). Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(2). 731–741. 19 indexed citations
8.
9.
Feuerbach, Dominik, Nicole Pezous, H. Weiss, et al.. (2014). AQW051, a novel, potent and selectiveα7 nicotinicAChreceptor partial agonist: pharmacological characterization and phaseIevaluation. British Journal of Pharmacology. 172(5). 1292–1304. 27 indexed citations
10.
Arias, Hugo R., Jhon J. López, Dominik Feuerbach, et al.. (2013). Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms. The International Journal of Biochemistry & Cell Biology. 45(11). 2420–2430. 16 indexed citations
11.
Arias, Hugo R., Avraham Rosenberg, Katarzyna M. Targowska‐Duda, et al.. (2010). Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states. The International Journal of Biochemistry & Cell Biology. 42(9). 1525–1535. 23 indexed citations
12.
Arias, Hugo R., Dominik Feuerbach, Katarzyna M. Targowska‐Duda, & Krzysztof Jóźwiak. (2010). Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors. Neurochemistry International. 57(2). 153–161. 8 indexed citations
13.
Arias, Hugo R., et al.. (2010). Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channel. Neurochemistry International. 56(4). 642–649. 30 indexed citations
14.
Feuerbach, Dominik, Kurt Lingenhoehl, Hans-Rudolf Olpe, et al.. (2008). The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology. 56(1). 254–263. 103 indexed citations
15.
Cammalleri, Maurizio, Davide Cervia, Massimo Dal Monte, et al.. (2006). Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. European Journal of Neuroscience. 23(9). 2404–2422. 38 indexed citations
16.
Loetscher, Erika, et al.. (2004). Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. European Journal of Pharmacology. 495(2-3). 97–102. 48 indexed citations
17.
Nunn, Caroline, Dominik Feuerbach, Xi Lin, Richard Peter, & Daniël Hoyer. (2001). Functional expression and pharmacological characterisation of the goldfish somatostatin sst5 receptor. British Journal of Pharmacology. 134. 42. 2 indexed citations
18.
Gazi, Lucien, et al.. (2000). Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D 4 receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(5). 555–564. 20 indexed citations
19.
Fehlmann, Dominique, et al.. (2000). Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. Journal of Physiology-Paris. 94(3-4). 265–281. 75 indexed citations
20.
Feuerbach, Dominik, Dominique Fehlmann, Caroline Nunn, et al.. (2000). Cloning, expression and pharmacological characterisation of the mouse somatostatin sst5 receptor. Neuropharmacology. 39(8). 1451–1462. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Izumi Hide Breakdown of academic impact, for papers by Eric Ronken Breakdown of academic impact, for papers by Marco Feligioni Breakdown of academic impact, for papers by Gabriel Olmos Breakdown of academic impact, for papers by Kerstin Iverfeldt Breakdown of academic impact, for papers by Agnès Petit-Paitel Breakdown of academic impact, for papers by Marta Barrachina Breakdown of academic impact, for papers by Umesh K. Jinwal Breakdown of academic impact, for papers by Ada De Luigi Breakdown of academic impact, for papers by Anna R. Carta
Rankless by CCL
2026